Total Lab Automation Market Size is valued at USD 508.9 Mn in 2023 and is predicted to reach USD 1,256.1 Mn by the year 2031 at a 12.1% CAGR during the forecast period for 2024-2031.
Total Lab Automation typically encompasses the complete automation of laboratory procedures, which involves integrating different instruments, systems, and software to optimize and improve the effectiveness of laboratory workflows. The objective of this technique is to minimize the need for human involvement, decrease mistakes, and enhance overall efficiency in scientific and clinical laboratories. It is one of the fast-evolving concepts involving integrating automated technology into laboratories to improve operations such as pipetting and data processing in various day-to-day laboratory processes. Technological improvements and increased pressure to give results have resulted in the deployment of automated systems in laboratories, which is boosting the market. Automated systems are becoming more popular because of their precision, better data management capacity, reduced repetitiveness, and reduced human intervention.
However, the COVID-19 pandemic has had a remarkable impact on a variety of industries, such as healthcare and diagnostics. The pandemic has also substantially impacted the Total Lab Automation (TLA) sector. The epidemic disrupted worldwide supply chains, disrupting laboratory reagents, consumables, and equipment availability. Laboratories with automated systems and integrated supply management skills were better positioned to handle these issues and keep testing operations running smoothly.
Competitive Landscape
Some Major Key Players In The Total Lab Automation Market:
- Bionex Solutions
- COPAN Diagnostics
- ERWEKA
- GeSim
- MGI
- Molecular Devices
- Nova Biomedical
- Pall Corporation
- Thermo Fisher Scientific
- Tecan Group
- Danaher Corporation
- Agilent Technologies
- Hoffmann-La Roche
- Perkinelmer
- Eppendorf
- Becton, Dickinson And Company
- Waters Corporation
- Siemens Healthineers
- Abbott Laboratories
- bioMérieux
- Endress+Hauser Group
- Hamilton Company
- Hudson Robotics
- Gilson, Inc.
- BMG Labtech
- Aurora Biomed Inc.
- Peak Analysis & Automation
- Formulatrix
- Qiagen N.V.
- Labvantage Solutions, Inc.
- Bio-Rad Laboratories, Inc.
- Labware
- Analytik Jena GMBH
- Others
Market Segmentation:
The Total Lab Automation Market is divided on the basis of application, and end-user. The application segment includes Diagnostics, Genomic Solutions, Microbiology, Drug Discovery, Proteomic Solutions, and Other Applications. By end-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Research & Diagnostic Laboratories, and Other End-Users.
Based On Application, The Diagnostics Segment Is A Major Contributor In The Total Lab Automation Market.
The diagnostics category is expected to hold a major share of the global Total Lab Automation Market in 2022. The rising frequency of chronic diseases, infectious outbreaks, and discrepancies in healthcare access fuel the demand for diagnostic testing. TLA systems help laboratories handle expanding demand by increasing testing capacity, efficiency, and turnaround time. Cancer therapies, including radiation therapy or proton therapy/precision therapy, target the area of the body where tumours are located. Increasing demographics, urbanization, penetration, and affordability will continue to drive market expansion for this application segment.
Pharmaceutical And Biotechnology Companies Segment Witnessed Rapid Growth.
The Pharmaceutical and Biotechnology Companies segment is likely to grow at a rapid rate in the Total Lab Automation Market due to the global presence of pharmaceutical businesses, as well as the increased adoption of robots and laboratory automation. Furthermore, laboratory automation has migrated from product manufacturing and quality control in laboratory applications and R&D within pharmaceutical businesses, which has fueled market growth.
In The Region, The North American Total Lab Automation Market Holds A Significant Revenue Share.
The North American Total Lab Automation Market is expected to record the maximum market revenue share in the near future. The presence of a well-established healthcare framework, as well as a solid need for automation systems throughout laboratories due to speed, uniformity, and precision, are linked to the region's rapid expansion. Rising demand for integrated laboratory systems, as well as supporting government regulations for research, are also driving the market. During the projection period, Asia Pacific is expected to be the fastest-growing region.
Factors such as the growing number of small and medium-sized laboratories in the region, as well as increased investments by regional market leaders to launch novel systems, are expected to drive regional market growth. Furthermore, favourable government measures to enable lab automation are another element driving the area market's rise.
Recent Developments:
- In Dec 2023, Abbott said that its latest laboratory automation system has obtained approval from the US Food and Drug Administration and is currently accessible in the US. The GLP Systems Track incorporates a self-propelled single sample carrier, known as CAR, which enables samples to travel autonomously without the need for a belt, as opposed to being connected to a stationary automated track system. The automation system is very adaptable and enables automated transportation of samples across the entire system.
- In Jan 2023, BD (Becton, Dickinson and Company) unveiled a novel robotic track system for the BD Kiestra™ microbiological laboratory solution. This system automates the processing of lab specimens, potentially leading to a decrease in human labour and wait times for results.
Total Lab Automation Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 508.9 Mn |
|
Revenue Forecast In 2031 |
USD 1,256.1 Mn |
|
Growth Rate CAGR |
CAGR of 12.1% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Application, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Bionex Solutions, COPAN Diagnostics, ERWEKA, GeSim, MGI, Molecular Devices, Nova Biomedical, Pall Corporation, Thermo Fisher Scientific, Tecan Group, Danaher Corporation, Agilent Technologies, F. Hoffmann-La Roche, Perkinelmer, Eppendorf, Becton, Dickinson And Company, Waters Corporation, Siemens Healthineers, Abbott Laboratories, bioMérieux, Endress+Hauser Group, Hamilton Company, Hudson Robotics, Gilson, Inc., BMG Labtech, Aurora Biomed Inc., Peak Analysis & Automation, Formulatrix, Qiagen N.V., Labvantage Solutions, Inc., Bio-Rad Laboratories, Inc., Labware, Analytik Jena GMBH |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
